MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Worsening tic disorder: Expanding the phenotype of IgLON5 disease

    S. Nagaratnam, S. Whyte (Gosford, Australia)

    Objective: To report on the possible association of motor tics and anti-IgLON5 disease Background: Anti-IgLON5 disease is an antibody-mediated neurodegenerative syndrome characterised by sleep disorders,…
  • 2022 International Congress

    Analyzing early states of HD progression using a machine learning driven approach

    E. Eyigoz, S. Sathe, J. Warner, S. Dey, T. Li, P. Rojas, C. Sampaio, J. Hu (Yorktown Heights, USA)

    Objective: Our aim is to build an early state HD progression model (EHDPM), a sub-model to Integrated Huntington’s Disease Progression Model (IHDPM) [1] to identify…
  • 2022 International Congress

    A child with infantile onset paroxysmal episodes of jerks and stiff limbs

    A. Das, A. Elavarasi, R. Singh, D. Vibha, M. Tripathi (Delhi, India)

    Objective: To present a child with ADCY5 related movement disorder having clinical response to steroids. Background: A 17 year old female, with delayed developmental milestones…
  • 2022 International Congress

    Association of type 2 diabetes and dementia in elderly patients with Parkinson’s disease: a population-based study in Korea

    S. Lee, J. Lee, D. Kim, H. Kim, M. Choi, S. Jo, S. Chung (Seoul, Republic of Korea)

    Objective: This study aimed to investigate the impact of type 2 diabetes (T2DM) on the development of dementia in patients with Parkinson’s disease (PD). Background:…
  • 2022 International Congress

    The Vall d’Hebron Initiative for Parkinson (VHIP) cohort: a prospective, longitudinal and observational study enrolling de novo Parkinson’s disease (PD) patients and carriers of PD-linked mutations for biomarker and pathophysiology studies

    D. Samaniego-Toro, L. Domingo-Rodriguez, M. Camprodon-Gómez, M. Armengol-Bellapart, V. González, S. Lucas-Del-Pozo, E. Xicoy, J. Riera-Heredia, D. Montpeyó, M. Martinez-Vicente, A. Laguna, J. Hernandez-Vara (Barcelona, Spain)

    Objective: To describe the study protocol of the Vall d’Hebron Initiative for Parkinson (VHIP) cohort, a prospective, longitudinal and observational cohort study aimed at deeply…
  • 2022 International Congress

    Beyond the subthalamic nucleus: tractography patterns of Magnetic Resonance-guided Focused Ultrasound subthalamotomy

    R. Rodriguez-Rojas, JU. Mañez-Miro, JA. Pineda-Pardo, R. Martinez-Fernandez, M. Del Alamo, JA. Obeso (Madrid, Spain)

    Objective: To identify subthalamic clusters that predict maximum improvement in bradykinesia, rigidity and tremor. To map-out the cortical fingerprint, which predict maximum efficacy. Background: Subthalamotomy…
  • 2022 International Congress

    A novel alpha-synuclein gene (SNCA) missense variant in an Austrian familiy with atypical neuropathological features

    C. Brücke, M. Zech, T. Outeiro, E. Gelpi, A. Zimprich (VIenna, Austria)

    Objective: To offer clinical, genetic and neuropathological information in a novel alpha-synuclein gene (SNCA) missense variant to further our understanding of synucleinopathies. Background: Around 5–10% of…
  • 2022 International Congress

    Validation of a wireless Home-Based Sleep Laboratory for assessment of sleep-related disorders in Parkinson’s disease

    S. Oz, A. Dagay, S. Katzav, D. Wasserman, E. Harduff, Y. Hanein, A. Mirelman (Tel Aviv, Israel)

    Objective: To examine the validity of a new wireless wearable system which measures EEG, EOG and sEMG for the assessment of sleep and sleep related…
  • 2022 International Congress

    Does needle size matter in botulinum toxin injection? A crossover randomised controlled trial of microneedle in patients with hemifacial spasm

    S. Maytharakcheep, R. Bhidayasiri, O. Phokaewvarangkul (bangkok, Thailand)

    Objective: The aim of this study was to compare the severity of  pain and bruises between a microneedle (34-G) and standard needle (30-G) in patients…
  • 2022 International Congress

    What research participants want to know: Feedback from participants in an observational study of Parkinson’s disease

    S. Lettenberger, S. Jensen-Roberts, E. Wagner, M. Pawlik, J. Soto, E. Hartman, P. Yang, E. Nnadika, C. Tarolli, R. Schneider, J. Adams, E. Dorsey, T. Myers (Rochester, USA)

    Objective: To compare participant feedback regarding clinical assessments, patient-reported outcomes (PROs), and digital technologies provided in individual research reports in an observational study of Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 91
  • 92
  • 93
  • 94
  • 95
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley